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Abstract Genes differentially expressed in association with
disruption of the metallothionein gene were screened using two
hepatic stellate cell lines isolated and established from the livers
of normal 129/Sv (IMS/N cells) and transgenic mice deficient in
the genes for metallothionein-I and -II (IMS/MT (3) cells). We
found one cDNA (tentatively named NM31) that was expressed
only in IMS/N cells. Transfecting IMS/MT (3) cells with the
genes for both metallothionein-I and -II resulted in NM31
expression. These results suggest that metallothionein is essential
for NM31 gene expression. The nucleotide sequence of NM31
(294 bp) was identical to the 3P region of 3.1 mRNA (PTZ 17),
which is abundant in the embryonic mouse brain and is related
to chemically induced seizures. The present study indicates
that metallothionein mediates the expression of specific genes.
This is a novel explanation for some of the functions of
metallothionein. ß 2000 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Metallothionein(s) is a small protein found in most eukary-
otic species. Cysteine residues account for approximately 30%
of the total amino acid content of metallothionein [1,2] which
has roles in protection against the toxic e¡ects of heavy met-
als, xenobiotics and Q-irradiation, as well as in drug resistance,
homeostasis of essential metals and free radicals scavenging
[1,3^5]. The high content and intermolecular localization of
cysteine residues in metallothionein are highly conserved
among species; these facts are considered to be extremely
important to metallothionein function [1,6]. On the other
hand, nuclear localization of metallothionein in mammalian
cells has been reported by several investigators [7^9], indicat-
ing that metallothionein may also be associated with nuclear
functions. We speculated that metallothionein is involved in
gene expression. We therefore screened the genes that are ex-
pressed when the metallothionein gene is disrupted.
2. Materials and methods
2.1. Isolation and immortalization of stellate cells
According to the method of Kitamura et al. [10], hepatic stellate
cells were isolated from the livers of transgenic mice de¢cient in the
genes for metallothionein-I and -II [11] and from normal 129/Sv mice.
The cells obtained were immortalized by infection of SV40 virus. To
con¢rm immortalization, expression of SV40 T antigen was deter-
mined by RT-PCR (to be described in detail elsewhere).
2.2. Di¡erential display screening
Total RNA was extracted from exponentially growing cells or from
mouse liver using guanidinium thiocyanate-phenol-chloroform [12].
Di¡erential display proceeded as described by Liang and Pardee
[13]. Total RNA (0.1 Wg) was converted to single-stranded cDNA
using MMLV-reverse transcriptase and primers anchored by one
base in a volume of 20 Wl. The solution (1 Wl) containing cDNA
was then added to a PCR reaction mixture (10 Wl) containing 2 WM
of the anchored and random primers, 2 WM dNTP, 0.5 WCi of
[K-32P]dCTP and 0.5 units of Taq polymerase (Boehringer). PCR pro-
ceeded using a thermal cycler (MP; Takara) through 40 cycles of 94‡C
for 30 s, 40‡C for 2 min and 72‡C for 30 s followed by 72‡C for 5 min.
The ampli¢ed cDNAs (3.5 Wl) were separated on a 6% sequencing gel,
blotted on 3M paper, dried and exposed to X-ray ¢lm. Bands of
interest were eluted from the gel by boiling in water. DNA was pre-
cipitated in ethanol, then re-ampli¢ed using the same primer set and
PCR conditions except the dNTP concentrations were 20 WM and no
isotope was added. PCR samples were separated on a 1.5% agarose
gel, extracted and used as a probe for Northern hybridization.
2.3. Northern blot analysis
Total RNA (20 Wg) was resolved by electrophoresis on 0.8% aga-
rose/formaldehyde gels, then transferred to nylon membrane (Hy-
bond-N+, Amersham), and UV cross-linked. The membrane was
then hybridized overnight with random-primed [32P]dCTP-labelled
cDNA fragments obtained as above. The membrane was washed
and exposed to X-ray ¢lm overnight at 380‡C with an intensifying
screen. The membrane was stripped and re-probed with 32P-labelled
GAPDH cDNA as an internal control.
2.4. Gene transfer
IMS/MT (3) cells were incubated with a calcium phosphate precip-
itate containing 12 Wg of DNA (10 Wg of pKH plasmid containing the
MT-I and -II genes [14] and 2 Wg of pcDEBD containing hygromycin-
B phosphotransferase as a selective marker) for 7 h. This mixture was
replaced with normal medium and incubated for a further 48 h. Stably
transfected cells were selected by culture in the presence of hygrom-
ycin-B (300 Wg/ml, Boehringer) for about 14 days. Clones resistant to
hygromycin-B were selected and expanded.
3. Results and discussion
We isolated and established SV40-immortalized stellate cell
lines from the livers of transgenic mice de¢cient in the genes
for metallothionein-I and -II [11] and from normal 129/Sv
mice (controls). These cells were designated as IMS/MT (3)
(immortalized mouse stellate cells from MT-null mouse) and
IMS/N (immortalized mouse stellate cells from normal
mouse), respectively. We examined total RNA samples from
both cell lines by di¡erential display [13], and we found one
cDNA (tentatively named NM31) that was expressed only in
IMS/N cells (Fig. 1a). Northern hybridization using NM31 as
a probe con¢rmed that this gene was expressed at negligible
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levels in IMS/MT (3) cells (Fig. 1b). These results suggested
that metallothionein(s) is involved in NM31 gene expression.
To con¢rm this notion, plasmid pKH containing mouse met-
allothionein-I and -II genes [14] (a kind gift from Dr. R.D.
Palmiter) was introduced into IMS/MT (3) cells. Stable trans-
formants called IMS/MT (3)/pKH, expressed both normal
and disrupted mutant metallothionein I and II mRNA as
shown in Fig. 2a. Synthesis of metallothionein protein was
induced by zinc chloride in IMS/N and IMS/MT (3)/pKH,
but not in IMS/MT (3) cells. Moreover, IMS/MT (3)/pKH
cells were signi¢cantly less sensitive than IMS/MT (3) cells to
cadmium, indicating that IMS/MT (3)/pKH cells produce
functional metallothionein proteins. We then compared the
level of NM31 gene expression in IMS/MT (3) and IMS/
MT (3)/pKH cells by Northern hybridization. NM31 was
expressed at high levels in IMS/MT (3)/pKH cells (Fig. 2b).
This ¢nding suggests that NM31 gene expression is essentially
mediated by metallothionein. It is believed that most of the
biological functions of metallothionein are due to an abun-
dance of cysteine residues. The present study presents a new
concept to explain the biological roles of metallothionein: it
may mediate the expression of speci¢c genes.
Next, we examined the e¡ect of induction of synthesis of
metallothionein on expression of NM 31. The level of expres-
sion of NM31 gene in IMS/N cells determined by Northern
blot analysis was not changed by the treatment with zinc
chloride whereas the mRNA level of metallothionein-I was
signi¢cantly increased. This result suggests that the basal level
of expression of metallothionein in IMS/N cells might be
enough to mediate the expression of NM31 gene.
The nucleotide sequence of NM31 (294 bp) was identical to
the 3P region of 3.1 mRNA [15], which is abundant in the
embryonic mouse brain. The gene for 3.1 mRNA is conserved
at least in the mouse and in humans, where it is mainly ex-
pressed in the cerebellum, hippocampus and olfactory bulb
[15]. On the other hand, Kajiwara et al. [16] also isolated
the gene for this 3.1 mRNA (PTZ17) as the gene related to
chemically induced seizures. The expression of 3.1 mRNA in
the mouse brain is signi¢cantly depressed by an intraperito-
neal administration of pentylenetetrazole, which induces seiz-
ures [16]. During the pentylenetetrazole-induced bursting ac-
tivity, which is characteristic of convulsions, intracellular
calcium is released from storage sites and moved to the inner
surface of the cell membrane in neurons [17,18]. The injection
of 3.1 mRNA into Xenopus oocytes potentiates the pentylene-
tetrazole-induced calcium inward current and an intracellular
calcium increase [16]. On the other hand, a brain-speci¢c iso-
form (MT-III) of metallothionein has been isolated and ob-
served to inhibit survival of cultured rat neurons and to be
de¢cient in the brains of patients with Alzheimer’s disease
[19,20]. Erickson et al. [21] reported that mice de¢cient in
metallothionein-III are more susceptible to seizures induced
by kainic acid. Therefore, metallothionein-III might play a
role in the expression of 3.1 mRNA in the brain. We could
not observe expression of metallothionein-III mRNA in both
IMS/MT (3) and IMS/N cells. We then transfected the metal-
lothionein-III gene into IMS/MT (3) cells to obtain trans-
formants stably expressing metallothionein-III (IMS/MT
(3)/MT-III). The levels of NM31 mRNA in IMS/MT (3)/
MT-III cells determined by Northern hybridization were al-
most equivalent to IMS/N cells (data not shown). These re-
sults suggest that NM31 gene expression is also mediated by
metallothionein-III. It is possible to conclude that metallo-
thioneins might be involved in chemically induced seizures
by mediating 3.1 mRNA gene expression.
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